Filing Details
- Accession Number:
- 0001225208-14-020831
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-01 17:58:16
- Reporting Period:
- 2014-10-01
- Filing Date:
- 2014-10-01
- Accepted Time:
- 2014-10-01 17:58:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1489393 | Lyondellbasell Industries N.v. | LYB | Industrial Organic Chemicals (2860) | 980646235 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1500309 | B. Craig Glidden | 4Th Floor One Vine Street London X0 W1J 0AH | Evp & Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Ordinary Shares | Acquisiton | 2014-10-01 | 13,003 | $13.11 | 222,121 | No | 4 | M | Direct | |
Class A Ordinary Shares | Disposition | 2014-10-01 | 334 | $106.84 | 221,787 | No | 4 | S | Direct | |
Class A Ordinary Shares | Disposition | 2014-10-01 | 5,278 | $105.94 | 216,509 | No | 4 | S | Direct | |
Class A Ordinary Shares | Disposition | 2014-10-01 | 7,391 | $105.07 | 209,118 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Ordinary Shares | Opt - Stock Option | Disposition | 2014-10-01 | 13,003 | $0.00 | 13,003 | $13.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
39,009 | 2020-04-30 | No | 4 | M | Direct |
Footnotes
- The exercise of stock options and sale of the shares acquired upon exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014.
- Includes 201,716 restricted stock units granted pursuant to the issuer's long-term incentive plan: 19,612 granted on April 30, 2010 that vest on April 30, 2015 and 182,104 granted on April 30, 2010 that vest on April 30, 2015.
- This transaction was executed in multiple trades at prices ranging from $106.82 to $106.90. The price reported above reflects the weighted-average sale price. The reporting person herby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $105.5544 to $106.4213. The price reported above reflects the weighted-average sale price. The reporting person herby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $104.54 to $105.52. The price reported above reflects the weighted-average sale price. The reporting person herby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The reporting person was granted 356,666 stock options on April 30, 2010 which vested in three equal installments on the 2nd, 3rd and 4th anniversaries of the date of grant.